Medicinova (MNOV) Enterprise Value (2010 - 2026)
Medicinova (MNOV) posted quarterly Enterprise Value of -$30.8 million for Q4 2025, up 23.67% year-over-year from -$24.9 million in Q4 2024, and up 5.39% quarter-over-quarter from -$32.6 million in Q3 2025.
Medicinova (MNOV) Enterprise Value (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Enterprise Value for 16 consecutive years, with -$30.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value rose 23.67% year-over-year to -$30.8 million; the TTM figure through Dec 2025 stood at -$30.8 million (up 23.67% YoY), while the FY2025 annual figure was -$30.8 million, up 23.67% from the prior year.
- Enterprise Value climbed to -$30.8 million in Q4 2025 per MNOV's latest filing, from -$32.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$30.8 million in Q4 2025 and bottomed at -$77.8 million in Q2 2021.
- Historically, Enterprise Value has averaged -$53.2 million across 5 years, with a median of -$52.0 million in 2022.
- Annual changes were most pronounced in 2021 — Enterprise Value declined 28.71% — and 2022, when it surged 30.01%.
- Medicinova's Enterprise Value stood at -$71.4 million in 2021, then advanced by 18.12% to -$58.5 million in 2022, then gained by 12.8% to -$51.0 million in 2023, then gained by 20.86% to -$40.4 million in 2024, then increased by 23.67% to -$30.8 million in 2025.
- Business Quant data shows MNOV's Enterprise Value at -$30.8 million in Q4 2025, -$32.6 million in Q3 2025, and -$34.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | -25.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.42 Mn |
| Dec 31, 2025 | -30.81 Mn |
| Sep 30, 2025 | -32.56 Mn |
| Jun 30, 2025 | -34.26 Mn |
| Mar 31, 2025 | -36.57 Mn |
| Dec 31, 2024 | -40.36 Mn |
| Sep 30, 2024 | -42.28 Mn |
| Jun 30, 2024 | -44.34 Mn |
| Mar 31, 2024 | -47.14 Mn |
| Dec 31, 2023 | -51.00 Mn |
| Sep 30, 2023 | -51.51 Mn |
| Jun 30, 2023 | -52.88 Mn |
| Mar 31, 2023 | -55.26 Mn |
| Dec 31, 2022 | -58.49 Mn |
| Sep 30, 2022 | -52.51 Mn |
| Jun 30, 2022 | -65.23 Mn |
| Mar 31, 2022 | -67.70 Mn |
| Dec 31, 2021 | -71.43 Mn |
| Sep 30, 2021 | -75.03 Mn |
| Jun 30, 2021 | -77.79 Mn |